Location: Home
  • search
  • go
  • Relate News
  • 2/8/2021Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
  • 2/8/2021Bayer Receives Approval for Nubeqa in China for the Treatment of Men ...
  • 2/8/2021Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
  • 2/8/2021CDE Issues the Technical Guidelines for Clinical Pharmacokinetics of T...
  • 2/8/2021BMS Granted Priority Review for NDA of Luspatercept in China
  • 2/8/2021IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...
  • 2/5/2021JBM Healthcare Debuts IPO on the Main Board of HKSE
  • 2/5/2021CMS Acquires Dermatology Specialty Firm Luqa
  • 2/5/2021NMPA Holds National Drug Registration and Post Marketing Regulation Co...
  • 2/4/2021Local Drugmakers Dominated China's 4th Round of National VBP Again, As...
  • 2/4/2021Roche Reports Solid Results in 2020 with Mixed China Performance Highl...
  • 2/4/2021Former UF Professor Indicted for Defrauding NIH and Concealed Conflic...
  • 2/4/2021CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...
  • 2/4/2021Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...
  • 2/4/2021Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline
  • 2/4/2021Boehringer Sues China's Qilu Pharma in the U.S. over Patent Infringeme...
  • 2/4/2021Changes To Biotech And Chemical Patent Examination - Recent Amendments...
  • 2/3/2021AJMC: China Pulls Out Stops for Biosimilar Development
  • 2/3/2021Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...
  • 2/3/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...
  • 2/3/2021Bayer's NDA for Finerenone Accepted in China
  • 2/3/2021Amgen/Celgene's NDA for Apremilast Accepted in China
  • 2/3/2021MNCs Secure Multiple New Drug Approvals in China
  • 2/3/2021Bayer's Nexavar Composition Patent Challenged and Invalidated in China
  • 2/2/2021More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...
  • 2/2/2021Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...
  • 2/2/2021Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)
  • 2/2/2021WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...
  • 2/2/2021Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...
  • 2/2/2021Innovent and Lilly Announce Chinese Approval of TYVYT Combo for nsq...
  • Page:227/801 Total number of articles:24028: [First][<<] [225] [226] [227] [228] [229] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group